XML 38 R22.htm IDEA: XBRL DOCUMENT
v3.23.3

Derivative Instruments | 9 Months Ended
--- | ---
Sep. 30, 2023
Derivative Instruments |
Derivative Instruments | 14. Derivative Instruments Derivatives Designated as Hedging Instruments ​ Net Investment Hedges ​ In September 2022, we entered into cross-currency interest rate swaps, which effectively convert a portion of our U.S. dollar-denominated fixed-rate debt to foreign currency-denominated fixed-rate debt in order to hedge the currency exposure associated with our net investment in foreign subsidiaries. As of September 30, 2023, we had cross-currency interest rate swaps outstanding with notional amounts of $1.55 billion and maturity dates ranging through 2028. ​ ​ ​ The effect of these net investment hedges on accumulated other comprehensive income and the condensed consolidated income statements for the three and nine months ended September 30, 2023 and 2022 was as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ | ​ | ​ | 2023 |  | 2022 | ​ | 2023 |  | 2022
Cross-currency interest rate swaps (included component) (1) | ​ | ​ | $ | (52,698) | ​ | $ | (26,141) | ​ | $ | (53,853) | ​ | $ | (26,141)
Cross-currency interest rate swaps (excluded component) (2) | ​ | ​ | ​ | 14,006 | ​ | ​ | 28,848 | ​ | ​ | 28,423 | ​ | ​ | 28,848
Total | ​ | ​ | $ | (38,692) | ​ | $ | 2,707 | ​ | $ | (25,430) | ​ | $ | 2,707
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | Location of | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ | gain or (loss) | ​ | 2023 |  | 2022 | ​ | 2023 |  | 2022
Cross-currency interest rate swaps (excluded component) (2) | Interest expense | ​ | $ | 5,505 | ​ | $ | 650 | ​ | $ | 16,699 | ​ | $ | 650
​
(1) | Included component represents foreign exchange spot rates.
(2) | Excluded component represents cross-currency basis spread and interest rates.
​ Cash Flow Hedges ​ As of September 30, 2023, we had derivatives designated as cash flow hedges on 50% of the Euro Term Loan Facilities (€750 million notional amount) and 68% of the USD term loan ($740 million notional amount). Amounts reported in accumulated other comprehensive loss related to interest rate swaps are reclassified to interest expense as interest payments are made on our debt. As of September 30, 2023, we estimate that an additional $11.7 million will be reclassified as a decrease to interest expense during the nine months ended September 30, 2023, when the hedged forecasted transactions impact earnings. ​ The effect of these cash flow hedges on accumulated other comprehensive income and the condensed consolidated income statements for the three and nine months ended September 30, 2023 and 2022 was as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ | ​ | ​ | 2023 |  | 2022 | ​ | 2023 |  | 2022
Interest rate swaps | ​ | ​ | $ | (538) | ​ | $ | 5,692 | ​ | $ | (12,912) | ​ | $ | 5,012
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | Location of | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ | gain or (loss) | ​ | 2023 |  | 2022 | ​ | 2023 |  | 2022
Interest rate swaps | Interest expense | ​ | $ | 3,845 | ​ | $ | 478 | ​ | $ | 6,688 | ​ | $ | 539
​ Fair Value of Derivative Instruments ​ The subsequent table presents the fair value of derivative instruments recognized in our condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, 2023 | ​ | December 31, 2022
​ |  | Assets (1) |  | Liabilities (2) |  | Assets (1) |  | Liabilities (2)
Cross-currency interest rate swaps | ​ | $ | 1,698 | ​ | $ | 84,890 | ​ | $ | — | ​ | $ | 108,621
Interest rate swaps | ​ | ​ | 30,784 | ​ | ​ | — | ​ | ​ | 17,120 | ​ | ​ | 252
​ | ​ | $ | 32,482 | ​ | $ | 84,890 | ​ | $ | 17,120 | ​ | $ | 108,873
(1) | As presented in our condensed consolidated balance sheets within other assets.
(2) | As presented in our condensed consolidated balance sheets within accounts payable and other accrued liabilities.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//815/tableOfContent + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration